This document discusses cancer stem cells, their origin and role in tumor recurrence. It notes that cancer stem cells are the target of new drug designs that aim to inhibit signaling pathways like Notch, Shh and Wnt/β-catenin in order to have clinical significance in treating cancer. The document provides information on cancer stem cells and encourages learning more at the provided website.